COMP <GO>
TRAW vs AZTR // EV/EBITDA & P/E VALUATION
Traws Pharma Inc. (NASDAQ) VS. Azitra Inc (NYSE) • 15-METRIC TALLY: TRAW 2
— AZTR 1
■ METRIC PARITY
LAST: $0.30 (-16.34%) • MKT CAP: $4.6M
valuation
—
LAST: $0.76 (-16.31%) • MKT CAP: $4.6M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRAW VS. AZTR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TRAW | AZTR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 68.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 1/9 | +2.00 | TRAW | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 25.8 | 40.7 | -14.83 | AZTR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.6M | $4.6M | $37.5K | TRAW | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TRAW REV | AZTR REV | TRAW GROSS % | AZTR GROSS % | TRAW FCF | AZTR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.8M | $0 | — | — | -$18.2M | -$11.2M |
| FY 2024 | $226.0K | $7.5K | — | — | -$29.8M | -$10.2M |
| FY 2023 | $226.0K | $686.0K | — | — | -$17.9M | -$7.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRAW // BETA —
AZTR // BETA —